Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

262 results about "Cortisol synthesis" patented technology

Amino acid. Cortisol raises the free amino acids in the serum by inhibiting collagen formation, decreasing amino acid uptake by muscle, and inhibiting protein synthesis. Cortisol (as opticortinol) may inversely inhibit IgA precursor cells in the intestines of calves.

Preparation method and application of tension sensor for monitoring cortisol in sweat

The invention discloses a preparation method and application of a tension sensor for monitoring cortisol in sweat. According to the scheme, on the basis of a stretchable electrode (SWNTs / PDMS) which is prepared by patterning in a manner that a single-walled carbon nanotube is subjected to suction filtration and transfer printing on polydimethylsiloxane, cortisol is used as an imprinting molecular template by utilizing an electrochemical deposition technology, and Prussian blue (PB) and pyrrole (Py) are electrically polymerized to prepare an electrochemical sensor of a molecularly imprinted polymer (MIP), so that the change of the concentration of cortisol in sweat can be monitored in real time; a reliable and practical method is provided for rapid and pressure-free pressure monitoring. A scanning electron microscope is used for electrode modification morphology characterization, and an electrochemical workstation is used for electrode sensing performance characterization. The sensor realizes the function of dynamically monitoring the day and night change rule of cortisol in sweat, and has the characteristics of real-time detection, high sensitivity and selectivity and good stability.
Owner:NANJING UNIV OF POSTS & TELECOMM

Anti-cortisol antibody, and reagent and kit for detecting cortisol

The invention discloses an anti-cortisol antibody or a cortisol detection reagent and kit, and relates to the field of antibodies. The anti-cortisol antibody disclosed by the invention comprises a heavy chain complementarity determining region and a light chain complementarity determining region, provides an important raw material source for detection of cortisol, and has good affinity or activity.
Owner:DONGGUAN PENGZHI BIOTECH CO LTD

Disease marker fluorescence instant detection method based on protein scaffold DNA-Cu2 + functional nanospheres

The invention belongs to the technical field of biological detection, and particularly relates to a disease marker fluorescence instant detection method based on protein scaffold DNA-Cu2 + functional nanospheres, which comprises the following steps: combining an insulin-like growth factor 1 (IGF-1) aptamer or cortisol aptamer, protein-DNA and DNA-metal ions; the protein scaffold DNA-Cu < 2 + > multifunctional integrated nanospheres are synthesized by a one-step method at room temperature. Based on the function integration of the nanosphere, one-step detection of IGF-1 or cortisol is realized, a plurality of analysis modes including fluorescence detection and smartphone-RGB are provided by combining a test strip and smartphone red, green and blue (RGB) analysis technologies, and a rapid and sensitive disease marker instant detection method is constructed. Finally, rapid and convenient detection of multiple markers in hundreds of clinical samples of multiple diseases is realized, and a new solution is provided for paper-based fluorescence POCT.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Anti-cortisol antibody, and reagent and kit for detecting cortisol

The invention discloses an anti-cortisol antibody or a cortisol detection reagent and kit, and relates to the field of antibodies. The anti-cortisol antibody disclosed by the invention comprises a heavy chain complementarity determining region and a light chain complementarity determining region, provides an important raw material source for detection of cortisol, and has good affinity or activity.
Owner:DONGGUAN PENGZHI BIOTECH CO LTD

Cortisol and sodium ion difunctional detection sensor and preparation method thereof

The invention discloses a cortisol and sodium ion difunctional detection sensor and a preparation method thereof, and belongs to the technical field of sensing detection, the cortisol and sodium ion difunctional detection sensor comprises a substrate layer, a sodium ion detection module and a cortisol detection module, the bionic micro-fluidic unit is provided with a plurality of runner holes, and an embedded capillary pump structure is arranged in each runner hole so as to guide liquid to be detected to the sodium ion detection module and the cortisol detection module; and the shielding layer covers the surface of the bionic micro-fluidic unit. The sodium ion detection module and the cortisol detection module are specifically designed, so that wide-range detection of sodium ion concentration and low-concentration detection of cortisol are realized, a high-altitude low-pressure environment of a pilot can be matched, the sodium ion concentration and the cortisol concentration of the pilot can be accurately detected, and the detection accuracy is improved. Accurate detection of the signs of the pilot in the high-altitude flight process is achieved.
Owner:HUAZHONG UNIV OF SCI & TECH

Composition for regulating skin mood as well as preparation method and application thereof

The invention relates to the technical field of cosmetics, and particularly discloses a composition for regulating skin emotion and a preparation method and application thereof. Comprising the following components: aesculus chinensis fruit dry powder, radix sophorae flavescentis dry powder, mint leaf dry powder, geranium leaf dry powder and a solvent. The invention provides a composition for regulating skin mood, which is prepared by compounding dried aesculus chinensis fruit powder, dried radix sophorae flavescentis root powder, dried mint leaf powder and dried geranium leaf powder, and the prepared composition can regulate endogenous'happy hormone 'neurotransmitters (beta-enorphin, cortisol, 5-hydroxytryptamine, noradrenaline and the like) of a human body through skin absorption. Moreover, unhealthy states such as skin sensitivity, tension, redness and swelling, stabbing pain and pruritus caused by mood and pressure problems can be effectively relieved, expression of pressure regulating genes is activated, skin mood is relieved, skin detoxification is promoted, external pollution is defended, oxidation resistance and inflammation diminishing are achieved, and skin is relieved and repaired.
Owner:SHENZHEN LLG BIOTECHNOLOGY CO LTD

Biomarker for predicting or diagnosing gestational diabetes and application thereof

ActiveCN120927978AComponent separationHealth-index calculationDihydrotachysterolErythronic acid
The invention belongs to the technical field of gestational diabetes diagnosis marker screening, and particularly relates to a biomarker for predicting or diagnosing gestational diabetes and application of the biomarker. The invention discloses a biomarker for predicting or diagnosing gestational diabetes mellitus, the biomarker is selected from one or more of hypoxanthine, cortisol, dihydrotachysterol and cycloleucine, and more preferably, the biomarker comprises hypoxanthine, cortisol, dihydrotachysterol, (3R, 4R)-D-ketolactone, creatine, cycloleucine and L-hydroorotic acid. The seven biomarkers disclosed by the invention can predict or diagnose gestational diabetes mellitus independently or jointly through plasma detection at the early pregnancy stage, effectively improve the early diagnosis rate of gestational diabetes mellitus and improve disease prognosis, and have clinical use and popularization values.
Owner:WUHAN METWARE BIOTECHNOLOGY CO LTD

Method for detecting aldosterone, cortisol, deoxycorticosterone and cortisone in plasma by magnetic bead assisted LC-MS / MS

The invention relates to the technical field of medical detection, in particular to a method for detecting aldosterone, cortisol, deoxycorticosterone and cortisone in plasma through LC-MS / MS. The method comprises the following steps: (a) mixing a plasma sample with an internal standard solution to obtain a mixed solution; (b) adding the mixed solution into the magnetic bead suspension, sequentially carrying out adsorption, weak washing, strong washing and elution, and collecting an eluent; (c) carrying out liquid nitrogen blowing and redissolving on the eluent, and then carrying out LC-MS / MS detection; wherein the surfaces of the magnetic beads are modified with steroid adsorption groups, and the target detection objects are aldosterone, cortisol, deoxycorticosterone and cortisone. The detection method is convenient and simple, the detection efficiency is higher than that of a traditional method, and a feasible solution is provided for promoting popularization and application of the LC-MS / MS technology in clinical practice.
Owner:ZHEJIANG PROVINCIAL PEOPLES HOSPITAL

Anti-aging composition for promoting communication between skin cells and application of anti-aging composition

The invention relates to an anti-aging composition for promoting skin intercellular communication and application thereof, and the composition comprises the following components: a camellia nitidissima flower extract, a bacillus fermentation product, an European basswood extract and safflower glucoside, the weight ratio of the golden camellia flower extract to the bacillus fermentation product to the European basswood extract to the safflower glucoside is (1-10): (1-8): (1-6): (0.1-1). The anti-aging composition provided by the invention can promote the activity of skin communication cells, enhance intercellular communication and interaction, give full play to the biological function of cells, and achieve the anti-aging effect; the composition has the effects of removing wrinkles, tightening, smoothing and repairing, can inhibit damage of cortisol to skin barriers, achieves the effects of repairing and relieving mood pressure, and can achieve the optimal effects of removing wrinkles, tightening, smoothing and repairing due to mutual synergism of the components.
Owner:N O D TOPIA (GUANGZHOU) BIOTECHNOLOGY CO LTD

Preparation method of nattokinase sustained-release microspheres

The invention belongs to the technical field of food or medicine, and particularly relates to a preparation method of nattokinase sustained-release microspheres, which comprises the following steps: mixing an emulsifier span-80 with liquid paraffin to obtain an oil phase; adding chitosan into an acetic acid solution to prepare a chitosan water solution as a water phase; dropwise adding the water phase into the oil phase to prepare W / O type emulsion, dropwise adding a cross-linking agent A into the emulsion to obtain chitosan microspheres, and taking a chitosan microsphere nattokinase solution and a cross-linking agent B to obtain nattokinase-chitosan core microspheres; mixing the nattokinase-chitosan core microsphere with a cortisol aptamer solution, and incubating to enable the aptamer to be combined on the surface of the nattokinase-chitosan core microsphere; and adding a casein-PEG copolymer solution and a cross-linking agent C into the microspheres to obtain the cortisol response type intelligent switch microspheres. The nattokinase release amount can be dynamically adjusted day and night, the circadian thrombus risk rhythm is matched, the anti-thrombus effect is remarkably improved, side effects are reduced, and the nattokinase can be widely applied to the fields of functional food and drugs.
Owner:JIANGSU XINYOU BIOLOGY CO LTD

Endocrine hypertension screening method based on immunological analysis

The invention relates to the technical field of medical detection, in particular to an endocrine hypertension screening method based on immunological analysis, which comprises the following steps: collecting a random urine sample, removing interferents by using a composite nano adsorbent, and synchronously detecting hormones such as aldosterone, methoxyadrenaline and cortisol and metabolites thereof by using a high-throughput immunity analyzer; integrating detection data based on a dynamic threshold algorithm to generate a screening report, carrying out weighted scoring on positive samples in combination with clinical features, screening high-risk candidate samples, carrying out 24-hour urine retest on the high-risk samples, and if a retest result is still positive, carrying out referral treatment to a specialized department for disease cause definite diagnosis; according to the method, the technical problems of complex sample treatment, low multi-step efficiency and high false positive rate in the prior art are solved, efficient and accurate screening of endocrine hypertension is realized, and reliable support is provided for early diagnosis and targeted treatment.
Owner:AFFILIATED HUSN HOSPITAL OF FUDAN UNIV

Concomitant administration of glucocorticoid receptor modulator relacorilant and CYP2C9 substrates

Relacorilant is useful in the treatment of hypercortisolism and cancer. Many drugs useful in treating hypercortisolism or cancer are metabolized by CYP2C9 enzymes. The effects of concomitant administration of relacorilant and a CYP2C9 substrate are disclosed herein.Relacorilant potently inhibited CYP2C9 in an in vitro test, indicating that co-administration of relacorilant and a CYP2C9 substrate would be expected to increase the CYP2C9 substrate plasma exposure more than five-fold in vivo. Significant reductions in CYP2C9 substrate doses would be expected to be required when administered with relacorilant.Surprisingly, no such increase in plasma exposure was seen in human studies. Applicant discloses that relacorilant may be safely co-administered with unmodified doses of a CYP2C9 substrate such as, e.g., tolbutamide, glimepiride, and glipizide. Relacorilant and unmodified doses of CYP2C9 substrate such as tolbutamide, glimepiride, and glipizide may be co-administered to treat hypercortisolism, or may be co-administered to a cancer patient.
Owner:CORCEPT THERAPEUTICS INC

Compounds for diagnosing and treating epilepsy syndromes, methods and uses thereof

The present disclosure relates to medical diagnostics and therapeutics, specifically methods and compositions for predicting and preventing Sudden Unexpected Death in Epilepsy (SUDEP) and / or; treating, preventing and / or ameliorating symptoms associated with epileptic seizure syndromes; particularly Dravet Syndrome. It involves the use of biomarkers, selected from cortisol, corticosterone, cortisone, aldosterone, adrenocorticotropic hormone (ACTH), or combinations thereof, to assess SUDEP risk. Additionally, the present subject-matter describes compositions containing cortisone, hydrocortisone, dexamethasone, fludrocortisone, prednisolone, ganaxolone, tetracosactide, adrenocorticotropic hormone (ACTH) or combinations thereof, in a therapeutically effective amount with a pharmaceutically acceptable carrier, adjuvant, or excipient for SUDEP prevention. The disclosure also includes the use of these compositions for treating, preventing, and / or ameliorating seizures in epilepsy patients, particularly those with Dravet Syndrome and / or preventing / predicting SUDEP.
Owner:BIOSTRIKE UNIPESSOAL LDA

Pyranopyridine compounds, methods of making, pharmaceutical compositions, and uses thereof

The application discloses a pyrano pyridine compound, a preparation method, a pharmaceutical composition and application thereof. The application provides a compound as shown in formula (I), a pharmaceutically acceptable salt or a stereoisomer thereof, the compounds have a strong inhibitory effect on aldosterone synthase, have little influence on cortisol synthase, have high selectivity and high safety, and can be used for preventing and / or treating various diseases related to aldosterone.
Owner:ZHEJIANG YANGLI PHARMACEUTICAL TECHNOLOGY CO LTD

Mass spectrometry assay for congenital adrenal hyperplasia

Methods are provided for detecting the amount of one or more CAH panel analytes (i.e., pregnenolone, 17-OH pregnenolone, progesterone, 17-OH progesterone, dehydroepiandrosterone (DHEA), androstenedione, testosterone, deoxycorticosterone, 11-deoxycortisol, and cortisol) in a sample by mass spectrometry. The methods generally involve ionizing one or more CAH panel analytes in a sample and quantifying the generated ions to determine the amount of one or more CAH panel analytes in the sample. In methods where amounts of multiple CAH panel analytes are detected, the amounts of multiple analytes are detected in the same sample injection.
Owner:QUEST DIAGNOSTICS INVESTMENTS INC

Sleep assisting system and method based on endocrine detection

The invention discloses a sleep assisting system and method based on endocrine detection, and relates to the technical field of medical health information.The sleep assisting system comprises an acquisition module used for acquiring brain wave signals and electrocardiogram data of a user and obtaining cortisol hormone level data through a wearable sensor; the model building module is used for building a human body circadian rhythm cycle model according to the cortisol hormone level data and the brain wave signals acquired by the acquisition module; the sleep state evaluation module is used for matching the human body circadian rhythm cycle model with the electrocardiogram data acquired by the acquisition module to obtain a sleep state evaluation result; the light adjusting module is used for adjusting indoor light according to the evaluation result of the sleep state evaluation module, guiding melatonin secretion and adjusting the sleep rhythm of the user. Through collaborative analysis of the multi-dimensional physiological signals, the circadian rhythm and sleep state of the user can be evaluated more accurately, and then sleep quality regulation and control are improved.
Owner:JILIN UNIV FIRST HOSPITAL

Cortisol sensor and methods of their use

PCT designated stage expiredWO2025005885A1Biological testingDNA AptamersMedicine
Disclosed herein is a cortisol sensor, comprising or consisting of: i) a metal nanoparticle; ii) a plurality of cortisol binding ligands conjugated to the surface of the metal nanoparticle; and iii) a plurality of peptides conjugated to the surface of the metal nanoparticle, for reducing non-specific binding of the cortisol binding ligands and / or improving stability of the metal nanoparticle in solution. In particular, the metal nanoparticle is a gold nanoparticle, the cortisol binding ligand is a cortisol DNA aptamer, and the peptide is CALNN. Also disclosed is a method of detecting the presence or quantity of cortisol in a sample, comprising or consisting the steps of: a) providing the cortisol sensor; b) contacting the cortisol sensor to the sample in a saline environment; and c) determining the degree of aggregation of the cortisol sensor. In particular, the degree of aggregation is measured by UV-visible spectroscopy.
Owner:AGENCY FOR SCI TECH & RES

Molecularly imprinted electrochemical sensor as well as preparation method and application thereof

The invention discloses a molecularly imprinted electrochemical sensor and a preparation method and application thereof.The sensor comprises an electrode and a pyrrolyl molecularly imprinted polymer film synthesized on the surface of the electrode in situ, and the preparation method comprises the following steps that 1, pyrrolyl compound polymeric monomers, metal nanoparticles and cortisol are added into a PBS buffer solution, mixing to obtain an electro-polymerization solution; (2) preparing a pyrrole-based molecularly imprinted polymer containing a cortisol template on the surface of an electrode by taking the electropolymerization solution as a raw material and adopting a CV electrochemical polymerization method to obtain a molecularly imprinted modified electrode; and (3) removing cortisol template molecules from the molecularly imprinted modified electrode in an eluent, thereby detecting the content of cortisol in a to-be-detected solution. The molecularly imprinted electrochemical sensor disclosed by the invention can be used for detecting the concentration of cortisol, is simple in preparation method and low in cost, has relatively high sensitivity and selectivity to cortisol, and has relatively good practicability and safety.
Owner:CENT SOUTH UNIV +3

Emotional beautifying composition containing camellia nitidissima flower extract and application thereof

The invention discloses an emotion beautifying composition containing a camellia nitidissima flower extract and application of the emotion beautifying composition, and relates to the technical field of cosmetics. The invention provides an emotional beautifying composition. The emotional beautifying composition is prepared from the following components in parts by weight: 0.1 to 5 parts of purple coneflower extract, 0.01 to 2 parts of tephros glauca seed extract, 0.01 to 3 parts of golden camellia flower extract and 0.1 to 3 parts of lactobacillus fermentation lysate. Aiming at the core problem of skin barrier gene (FLG / LOR) expression inhibition caused by cortisol rhythm disorder caused by emotional pressure, the invention provides a solution scheme of three-stage linkage of cortisol rhythm synchronization, barrier gene repair and nerve sensitivity regulation.
Owner:N O D TOPIA (GUANGZHOU) BIOTECHNOLOGY CO LTD

Application of lactobacillus muricatum in preparation of medicine for preventing and / or treating depression and medicine containing lactobacillus muricatum

The invention discloses application of lactobacillus muricatum in preparation of a medicine for preventing and / or treating depression in the technical field of microorganisms, and the lactobacillus muricatum is preserved in the China Industrial Microbiological Culture Collection Center (CICC) with the preservation number of CICC23140. Research finds that lactobacillus muricatum which is preserved in the China Industrial Microbiological Culture Collection Center and has the preservation number of CICC23140 has a good effect of improving and / or preventing and / or treating cortisol-induced depression, and inactivated lactobacillus muricatum can effectively prevent hippocampal neuron damage, reduce expression of inflammatory factors in the brain, prevent and treat cortisol-induced depression, and can be used for preventing and treating cortisol-induced depression. Not only can the anxiety symptom of depression be improved, but also dyskinesia can be relieved.
Owner:ZUNYI MEDICAL UNIVERSITY

Stem cell composition and application thereof in regulating sub-health

InactiveCN120037369AAntipyreticAnalgesicsInflammatory factorsChronic stress
The invention discloses a stem cell composition and application thereof in regulating sub-health. The stem cell composition comprises mesenchymal stem cells (MSCs) modified by fusion polypeptide and an anti-IL-6R single domain antibody. The amino acid sequence of the fusion polypeptide is as shown in SEQ ID NO.1, and the fusion polypeptide is modified on the surface of stem cells through click chemistry, so that the chemotactic migration ability, collagen matrix affinity and inflammation tolerance of the stem cells are remarkably improved. The anti-IL-6R single-domain antibody is obtained through phage display screening, the VHH gene of the anti-IL-6R single-domain antibody is shown as SEQ ID NO.2, and the anti-IL-6R single-domain antibody has high affinity and activity of inhibiting an IL-6 / STAT3 signal channel. Animal experiments show that the composition can significantly reduce inflammatory factor (IL-6) and cortisol levels of chronic stress model mice, improve oxidation resistance (SOD) and recover immune homeostasis, and provides an innovative treatment strategy for adjustment of sub-health status.
Owner:GUANGDONG GUANYIN PHARMACEUTICAL BIOTECHNOLOGY DEVELOPMENT CO LTD

Peptide combination for the control of aldosterone synthesis in the function of pressure control and disorders due to infectious and other diseases

The present Invention relates to a newly designed product, i.e. substance (B+C) that combines two different mechanisms of action that allow the control of aldosterone synthesis and secretion without compromising the metabolism of cortisol (corticosterone In rats) in the.tone glomerulosa of the adrenal gland. The innovative design of the described molecule enables ths individual use of substance (B+C) in the treatment of diseases such as hyper and hypo aldosteronism, Conn's syndrome and cytokine storm caused by Covid infection or as co-therapy with corticosteroids in the treatment of a whole range of immunological diseases. The innovative design of Substance (8+C) has an additional practical and economic advantage because the patient receives both components of substance (B+C) simultaneously with just one application, regardless of the medicine formulation. This not only simplifies the medicine synthesis, dosing and clinical research, but also the application of the medicine in clinical practice. For successful and selective control of aldosterone synthesis, which in nature also means selective control of blood pressure, it was necessary to combine the two substances described in order to ensure action in patients with elevated and / or towered blood pressure with one application of Substance (B+C). This feature of Substance (B+C) is important, especially in the treatment of patients with permanently impaired aldosterone synthesis, such as Conn's disease and similar autoimmune diseases, or in combmatton with corticosteroids where prolonged or repeated corticosteroid therapy is indicated. Finally, this invention is extremely important because It enables the safe treatment of a large group of patients with hypertension who also have secondary diseases of the immune system, various inflammations or viral Infections such as Covid where corticosteroid therapy is indicated, but difficult to implement in practice due to the negative effect of corticosteroids on blood pressure.
Owner:ADEMOVIĊ, ZLATKO

Synergetic compositions for women health

The present invention relates to an oral extract composition comprising Shatavari (Asparagus racemosus Willd.) and Fenugreek (Trigonella foenum-graecum L.) extract composition, and its process of preparation. Also relates to the oral extract composition formulation comprising with synergistic combinations of the Shatavari (Asparagus racemosus Willd.) and Fenugreek (Trigonella foenum-graecum L.) in suitable doses and at least one nutraceutically and / or pharmaceutically accepted excipient for, improvement, and maintenance of women health more preferably in improving of hot flashes, night sweats, poor sleep, anxiety, sexual dysfunction, mood changes, Genitourinary symptoms in overall improving the quality of life, serum estradiol, progesterone, follicle stimulating hormone (FSH), and cortisol during the period of menopause (perimenopause and menopause). The oral extract composition formulation comprising with synergistic combinations of the Shatavari (Asparagus racemosus Willd.) and Fenugreek (Trigonella foenum-graecum L.) in suitable doses and at least one nutraceutically and / or pharmaceutically accepted excipient is used for improving Brain-derived neurotrophic factor (BDNF) levels in women during the period of menopause. The present invention, further related to the extraction process of Shatavari (Asparagus racemosus Willd.) and Fenugreek (Trigonella foenum-graecum L.), also provides the process for the preparation of formulation composition. This invention further relates to the extraction process from Shatavari (Asparagus racemosus Willd.) and Fenugreek (Trigonella foenum-graecum L.) either as individual herbs or co-extraction of the two herbs or mixing the extracts at various stages of the individual extracts.
Owner:OMNIACTIVE HEALTH TECH LTD

Method for treating disease by levoketoconazole

ActiveJP2025026838AOrganic active ingredientsMetabolism disorderDiseaseAbnormal renal function
To provide a pharmaceutical composition for treating hypercortisolism in a subject of Cushing's syndrome.SOLUTION: A pharmaceutical composition contains levoketoconazole or a pharmaceutically acceptable salt thereof, and is administered to a subject in need thereof in a therapeutically effective amount. The pharmaceutical composition is administered with a therapeutically effective amount of metformin or a pharmaceutically acceptable salt thereof. The subject also has type 2 diabetes and has had previous surgery or radiation to treat Cushing's syndrome. The therapeutically effective amount of the pharmaceutical composition is determined via a titration scheme including dose escalation of the pharmaceutical composition. When the subject experiences a dose limitation event, metformin or a pharmaceutically acceptable salt thereof is administered at a dose that is less than the therapeutically effective amount. The dose limitation event is reduction of a fasting blood glucose level, an abnormal renal function, a low vitamin B-12 level or any combination thereof.SELECTED DRAWING: None
Owner:STRONGBRIDGE DUBLIN LTD

Formula of tea drink

The invention relates to a formula of a tea drink, and relates to the technical field of homology of medicine and food, and the formula is prepared by compounding nine components of double-petal red rose, Hetian jade jujube slices, dried mulberry, longan pulp, Ningxia wolfberry, Xinhui dried orange peel, raspberry, Hunan lotus seed pulp and licorice slices according to a specific proportion. Synergistic interaction is realized through triple action mechanisms, the liver soothing and depression relieving of the double-petal red rose is taken as a regulation and control core, the cortisol level is reduced, and endocrine imbalance is improved; on the basis of benefiting qi and nourishing blood by jujube slices and Chinese wolfberry fruits, dried mulberries and raspberries are enriched with natural folic acid and antioxidant substances, so that the egg cell quality and reproductive microcirculation are improved in a targeted manner; longan-Hunan lotus seed meat is used for warming uterus and tonifying spleen, and dried orange peel-licorice tablets are combined to enhance component absorption and compatibility stability. The preparation method comprises the steps of gradient drying, precise mixing and cobalt-60 irradiation sterilization. According to the scheme, the absorption bottleneck of traditional substitutional tea is broken through, the bioavailability is improved, and the compound sub-health problems of female endocrine disorder, follicular development disorder and cold uterus and weak body are quantitatively solved.
Owner:YIKANGDA (SHENZHEN) PHARMACEUTICAL CONSULTING CO LTD

Compositions for enhancing exercise endurance and their applications

The present invention belongs to the technical field of medicine and food homologous compositions, and discloses a composition for enhancing exercise endurance and its applications. It is found that the composition has the following effects: (1) After 30 minutes of intervention with a high dose of the composition, exercise endurance can be significantly enhanced, and it can affect exercise endurance by regulating the levels of hormones such as testosterone and cortisol. (2) Intervention with the composition for 14 days can significantly prolong the swimming time to exhaustion under negative gravity in mice, reduce the accumulation of harmful metabolites, thereby increasing the body's energy metabolism and reducing the degree of fatigue of the body. (3) Intervention with a high dose of the composition for 28 days can significantly increase exercise endurance, and by increasing the muscle glycogen reserve and reducing the accumulation of harmful metabolites such as urea nitrogen and lactic acid, the effect of improving exercise endurance is achieved.
Owner:GUANGDONG OCEAN UNIVERSITY

Microbial compositions to increase the production of PCA from polyphenols

Compositions and methods for converting at least one polyphenol to protocatechuic acid (PCA) using Bacillus subtilis 1579, or active variants thereof, are provided. Conversion of polyphenols, such as quercetin, to PCA can decrease inflammation, decrease cortisol levels, and increase milk quality and milk production quantity in milk-producing agricultural animals. Accordingly, provided herein are compositions comprising B. subtilis 1579, or an active variant thereof, for administration to humans for decreasing inflammation or for administration to milk-producing agricultural animals for decreasing inflammation, decreasing cortisol levels, and increasing milk quality and milk production.
Owner:CHURCH & DWIGHT CO INC

Application of circium japonicum extract

The invention discloses application of a circium japonicum extract. The circium japonicum extract is applied to preparation of products for preventing skin problems caused by cortisol unbalance. The invention also relates to application in preparation of products for relieving skin problems caused by cortisol imbalance. The circium japonicum extract can improve skin problems caused by excessive transformation of cortisol and increase the expression quantity of dermal collagen, skin barrier related protein and skin basement membrane related protein, so that the problems of skin barrier damage, skin sensitivity, wrinkle generation, skin elasticity reduction and the like caused by emotional pressure are effectively relieved.
Owner:上海致臻志臣科技有限公司